Title |
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
|
---|---|
Published in |
Thorax, June 2014
|
DOI | 10.1136/thoraxjnl-2013-204114 |
Pubmed ID | |
Authors |
Stephen O'Neill, Joan Sweeney, Chris C Patterson, Andrew Menzies-Gow, Rob Niven, Adel H Mansur, Christine Bucknall, Rekha Chaudhuri, Neil C Thomson, Chris E Brightling, Ciaran O'Neill, Liam G Heaney |
Abstract |
Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were £2912 (SD £2212) to £4217 (SD £2449). Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 15% |
United Kingdom | 1 | 8% |
Argentina | 1 | 8% |
Unknown | 9 | 69% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 54% |
Scientists | 3 | 23% |
Practitioners (doctors, other healthcare professionals) | 2 | 15% |
Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 165 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 25 | 15% |
Student > Bachelor | 20 | 12% |
Student > Ph. D. Student | 19 | 12% |
Other | 15 | 9% |
Student > Master | 13 | 8% |
Other | 22 | 13% |
Unknown | 51 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 57 | 35% |
Economics, Econometrics and Finance | 9 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Nursing and Health Professions | 5 | 3% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Other | 26 | 16% |
Unknown | 56 | 34% |